| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/02/2008 | CA2318848C 5'-deoxycytidine derivatives |
| 09/02/2008 | CA2314238C Synthesis of combretastatin a-4 prodrugs and trans-isomers thereof |
| 09/02/2008 | CA2294351C Compounds useful for inhibition of farnesyl protein transferase |
| 09/02/2008 | CA2271244C Pressure-mediated intracellular delivery of molecules or microparticles |
| 09/02/2008 | CA2246430C Protein tyrosine phosphatases of hematopoietic cells |
| 09/02/2008 | CA2131662C Improved prodrugs for enzyme mediated activation |
| 08/28/2008 | WO2008103636A1 Imidazoquinolines as dual lipid kinase and mtor inhibitors |
| 08/28/2008 | WO2008102912A1 Target protein and target gene for drug discovery, and screening method |
| 08/28/2008 | WO2008102888A1 Novel pseudoglycolipid and use thereof |
| 08/28/2008 | WO2008102881A1 ANALOGUE OF MAPKK NUCLEAR EXPORT INHIBITOR peumusolide A AND USE THEREOF |
| 08/28/2008 | WO2008102859A1 Agent for prevention and/or treatment of anxiety disorders |
| 08/28/2008 | WO2008102777A1 Ameliorating agent for insulin resistance |
| 08/28/2008 | WO2008102749A1 Heterocyclic compound |
| 08/28/2008 | WO2008102669A1 Novel sugar-linked chlorin derivative and process for production thereof |
| 08/28/2008 | WO2008101406A1 Modified mutant collagenase and it's use in fat melting and in scar reduction |
| 08/28/2008 | WO2008065666A3 Uses of incensole, incensole acetate and derivatives thereof |
| 08/28/2008 | US20080208167 Methods and compositions to treat myocardial conditions |
| 08/28/2008 | US20080207902 Phosphodiesterase inhibitors; side effect reduction |
| 08/28/2008 | US20080207764 Novel Benzamidine Derivatives Having Anti-Inflammatory and Immunosuppressive Activity |
| 08/28/2008 | US20080207759 Prevent damage in mammals by administering prostaglandins |
| 08/28/2008 | US20080207746 Administering an ultrasonic contrast agent; imaging tissue; medical diagnosis; using halogenated xanthene compound |
| 08/28/2008 | US20080207737 Methods for the Treatment of Hyperhidrosis |
| 08/28/2008 | US20080207730 Methods of using (+)-2-[1-(3-Ethoxy-4 methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione |
| 08/28/2008 | US20080207709 -4-[2-(aminomethyl)-1,3-thiazol-4-yl]-2,6-di(tert-butyl)phenol; : 4-[2-(aminomethyl)-1,3-thiazol-4-yl]-2,6-di(tert-butyl)phenol hydrochloride or dihydrochloride |
| 08/28/2008 | US20080207680 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents |
| 08/28/2008 | US20080207656 Methods, compositions, and kits for organ protection during systemic anticancer therapy |
| 08/28/2008 | US20080207642 Respiratory system disorders; asthma; chronic obstructive pulmonary diseases; autoimmune diseases; antiproliferative agents; anticancer agents |
| 08/28/2008 | US20080207636 Using a benzmide compound; antidiabetic agents; obesity |
| 08/28/2008 | US20080207625 Synthesis and Purification of Pteroic Acid and Conjugates Thereof |
| 08/28/2008 | US20080207617 Prevent autophosphorylation of tyrosine kinase; therapy for hematopoietic cancer; leukemia; myelodysplastic syndrome |
| 08/28/2008 | US20080207608 Stroke; antiinflammatory agents; sepsis; allograft; transplant rejection; antitumor agents; liver disorders; brain hemorrage; neurodegenerative diseases ; vision defects |
| 08/28/2008 | US20080207602 Succinoylamino benzodiazepines as inhibitors of abeta protein production |
| 08/28/2008 | US20080207590 Inhibitors of Histone Deacetylase |
| 08/28/2008 | US20080207576 Substituted sapogenins and their use |
| 08/28/2008 | US20080207566 Methods for the administration of amifostine and related compounds |
| 08/28/2008 | US20080207555 Catalyzing the release of ADP-ribose from poly(ADP-ribose) or O-acetyl-ADP-ribose by contacting with an isolated ARH3 polypeptide; modifying DNA repair or chromatin structure by modifying ARH3 polypeptide activity; drug screening; antiinflammatory, antiischemic agents; aging resistance |
| 08/28/2008 | US20080207552 Decoy compositions for treating and preventing brain diseases and disorders |
| 08/28/2008 | US20080207550 Immunomodulatory polynucleotides and methods of using the same |
| 08/28/2008 | US20080207549 An antisense polynucleotide or short interfering RNA; diagnosis of proliferative diseases; targets for drug design; antiproliferative agents |
| 08/28/2008 | US20080207546 Rna aptamers and methods for identifying the same |
| 08/28/2008 | US20080207541 Compositions and Methods For Optimizing Cleavage of Rna By Rnase H |
| 08/28/2008 | US20080207538 Enhanced Production of Functional Proteins From Defective Genes |
| 08/28/2008 | US20080207513 Compositions For Buccal Delivery of Human Growth Hormone |
| 08/28/2008 | US20080207511 Isolated polypeptide comprising amino acid sequence encoded by polynucleotide; physiologically acceptable carriers and immunostimulants |
| 08/28/2008 | US20080207504 SECRETED FRIZZLED RELATED PROTEIN, sFRP, FRAGMENTS AND METHODS OF USE THEREOF |
| 08/28/2008 | US20080207491 Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections |
| 08/28/2008 | US20080206365 2-hydroxy-2-substituted-3,10a-ethanophenanthrolines; inhibitors or activators for cytokine production; viricide, antiarthritic, anticarcinogenic, anticholesterol agents; myocardial infarction, osteoporosis, diabetes complications, sepsis, myeloma, transplant rejection, cirrhosis, AIDS, multiple sclerosis |
| 08/28/2008 | US20080206340 Galactomannans and/or Glucomannans For Increasing the Bioavailability of Active Substances |
| 08/28/2008 | US20080206312 Therapeutic Morpholino-Substituted Compounds |
| 08/28/2008 | US20080206308 comprising a biodegradable unsaturated polymer selecting from polypropylene fumarate and polycaprolactone fumarate and a curing agent to form a porous scaffold in an mold or in a body cavity; for tissue regeneration; drug delivery devices; biodegradable, biocompatible scaffolds for tissue engineering |
| 08/28/2008 | US20080206257 Reducing epithelial toxicity during cancer therapy by administering KGF with e.g. erlotinib, Iressa(TM), canertinib, or a monoclonal antibody against EGFR; side effect reduction of diarrhea, rash |
| 08/28/2008 | US20080206255 Antibody cancer immunotherapy |
| 08/28/2008 | US20080206252 Novel Polypeptides, and Nucleic Acids Encoding the Same |
| 08/28/2008 | US20080206249 comprise one or more breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides |
| 08/28/2008 | US20080206240 Antilymphocyte Antibody Induction |
| 08/28/2008 | US20080206223 Treatment of pompe's disease |
| 08/28/2008 | US20080206215 Promoting yeast propagation, conditioning and efficiency in fluid stream via enhancing carbohydrate and cellulose concentration of fermentation broth |
| 08/28/2008 | US20080206209 Myelinating or remyelinating dysmyelinated or demyelinated axons comprising: administering oligondendrocyte progenitor cells to dysmyelinated or demyelinated axons via intraventricular, intracallosal or intraparenchymal administration to brain, brain stem or spinal cord |
| 08/28/2008 | US20080206205 Using immunoaffinity, ficoll centrifugation and fluorescent cell sorting to isolate cells express ing cd34 antigen; treating cell proliferative disorders |
| 08/28/2008 | US20080206186 Tissues; 20 mol% acidic monmers: acrylic acid, monoacryloxyethyl phosphate, propene-1-sulfonic acid, vinyl benzoic acid, crotonic acid, itaconic acid, vinylsulfonic acid, vinyl acetic acid, citric acid, styrene sulfonic acid, sodium styrene sulfonate; porosity of at least 40%; interconnected pores |
| 08/28/2008 | US20080206163 INHIBITORS OF PHOSPHODIESTERASE (PDE) ISOENZYMES; USEFUL FOR TREATMENT OF RESPIRATORY DISORDERS SUCH AS ASTHMA; chronic obstructive pulmonary disease (COPD); 9,10-Dimethoxy-2-(2,4,6-trimethylphenylimino)-3-(N-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one |
| 08/28/2008 | US20080206162 Composition and Methods for Treating Alzheimer's Disease and Other Amyloidoses |
| 08/28/2008 | US20080206140 Antibodies specific to malignant cancer specific proliferating cell nuclear antigen (csPCNA) and not to the non-malignant proliferating cell nuclear antigen (nmPCNA) isoform; cancer diagnosis, prognosis, tumor detection and therapy; immunoassay kit |
| 08/28/2008 | US20080206136 Binding Peptidomimetics and Uses of the Same |
| 08/28/2008 | US20080206133 Patient-specific anticancer monoclonal antibodies for staging and diagnosis of a cancer, treating tumors and metastases; monoclonal antibody produced by hybridoma; conjugates with cytotoxic agents for tissue-targeted therapy |
| 08/28/2008 | US20080206132 Cancerous Disease Modifying Antibodies |
| 08/28/2008 | DE10164893B4 Verfahren zur Herstellung von Artischockenblätterextrakten und so erhaltene Artischockenblätterextrakte Process for the preparation of artichoke leaf extracts and extracts so obtained artichoke leaves |
| 08/28/2008 | CA2678757A1 Ameliorating agent for insulin resistance |
| 08/28/2008 | CA2676786A1 Imidazoquinolines as dual lipid kinase and mtor inhibitors |
| 08/27/2008 | EP1961811A1 Novel cytokine ZCYTOR17 ligand |
| 08/27/2008 | EP1961767A2 Diagnosis and treatment of cancers and other conditions |
| 08/27/2008 | EP1961756A1 Novel bisboron compound |
| 08/27/2008 | EP1961754A1 Bicyclic heterocyclic compound |
| 08/27/2008 | EP1961748A2 2-hydroxy-3-heteroarylindole derivatives as GSK3 inhibitors |
| 08/27/2008 | EP1961745A1 Bicyclic heterocyclic compound |
| 08/27/2008 | EP1961428A1 SC6 antibody for treatment of cancer |
| 08/27/2008 | EP1959964A1 Heteroaromatic sulfonamide prodrugs |
| 08/27/2008 | EP1959944A1 A pharmaceutical composition comprising an amide derivative |
| 08/27/2008 | EP1765776B1 Novel tetrahydrocarbazole derivatives with improved biological action and improved solubility as ligands for g-protein coupled receptors (gpcrs) |
| 08/27/2008 | EP1531814B1 Sustained-release tablet composition of pramipexole |
| 08/27/2008 | EP1474146B1 Phenylpyrimidine amines as ige inhibitors |
| 08/27/2008 | EP1467997B8 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 08/27/2008 | EP1384726B1 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 08/27/2008 | EP1337560B1 Truncated cd200 |
| 08/27/2008 | EP1313714B1 Valsartan salts |
| 08/27/2008 | EP1307188B1 Ajulemic acid for the treatment of cancer |
| 08/27/2008 | EP1228086B1 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES |
| 08/27/2008 | EP1210078B1 Improved topical medicaments and methods for photodynamic treatment of disease |
| 08/27/2008 | EP1089994B9 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same |
| 08/27/2008 | EP0952832B1 Quinoline carboxamides as tnf inhibitors and as pde-iv inhibitors |
| 08/27/2008 | EP0949931B1 Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases |
| 08/27/2008 | CN101253166A Sulfonamide compound |
| 08/27/2008 | CN101252952A Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid |
| 08/27/2008 | CN100413961C Inhibition of nuclear transcription factor NF- kappa B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-n-vanillyl-6-nonenamide) and resiniferatoxin |
| 08/27/2008 | CN100413883C Peptidic compounds selectively binding to p-selectin |
| 08/27/2008 | CN100413882C Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 08/27/2008 | CN100413881C Eplerenone crystalline form |
| 08/27/2008 | CN100413863C Novel 1,2,3-substituted indolizine derivatives, inhibitors of FGFs, method for making same and pharmaceutical compositions containing same |
| 08/27/2008 | CN100413860C Piperidine derivative as NMDA receptor antagonist |
| 08/27/2008 | CN100413852C Valsartan salts |